- $30.67m
- -$1.61m
- $36.08m
- 30
- 45
- 41
- 32
Annual cashflow statement for Equillium, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -25.6 | -29.8 | -39.1 | -62.4 | -13.3 |
| Depreciation | |||||
| Non-Cash Items | 1.92 | 3.89 | 5.2 | 53.6 | -6.03 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.711 | 1.25 | 1.7 | 0.019 | -2.55 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -22.9 | -24.6 | -32.1 | -8.73 | -21.8 |
| Capital Expenditures | -0.074 | -0.202 | -0.057 | -0.279 | -0.05 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2.09 | -18.4 | 27.5 | 19 | -4.71 |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -2.17 | -18.6 | 27.4 | 18.7 | -4.76 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.84 | 53.9 | 31.1 | -1.22 | -9.23 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -15.3 | 10.8 | 26.4 | 8.74 | -35.9 |